Category Archives: Medical Devices

Below, we are re-publishing with permission the press-release issued by Cardiovascular Systems Inc. on September 02, 2022 Cardiovascular Systems has an acquisition option agreement with the balloon’s developer, Chansu Vascular Technologies. Cardiovascular Systems Inc. (CSI) has begun enrolling patients in its … Continue reading →

Interview with the implanting physicians from the DurAVR First-in-Human Study

Below, we are re-publishing with permission the press-release issued by Vascular Dynamics, Inc. on October 18, 2022 Vascular Dynamics, Inc. (VDI), a privately held medical device company focused on developing game-changing endovascular device-based solutions for patients suffering from heart failure, … Continue reading →

Below, we are re-publishing with permission the press-release issued by Sequana Medical on November 15, 2022 15 November 2022, 07:00 am CET Ghent, Belgium – 15 November 2022 – Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” or “Sequana Medical“), a pioneer in the treatment of … Continue reading →

Below, we are re-publishing with permission the press-release issued by Maxwell Biomedical on October 20, 2022 Spatial Resynchronization Therapy (SR™T) demonstrates proof-of-concept in repeatedly terminating atrial fibrillation (AFib) and restoring sinus rhythm SAN DIEGO, CALIFORNIA, UNITED STATES, October 20, 2022 … Continue reading →

Below, we are re-publishing with permission the press-release issued by Axon Therapies on May 26, 2022 Late-breaking results presented at the European Society of Cardiology’s Heart Failure Association annual conference and simultaneously published online in the European Journal of Heart … Continue reading →

Below, we are re-publishing with permission the press-release issued by AtriAN Medical on September 06, 2022 This follow-up trial builds on AtriAN’s initial safety and feasibility study and aims to assess the efficacy of its cardioneuroablation treatment in patients with atrial … Continue reading →

Below, we are re-publishing with permission the press-release issued by Cardiovascular Systems, Inc. on March 16, 2022 ST. PAUL, Minn.–(BUSINESS WIRE)– Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with … Continue reading →